Dignitana AB, a pioneer in scalp cooling technology, has made an exciting announcement about a sales and marketing partnership with InfuSystem Holdings, Inc. InfuSystem is a prominent healthcare service provider that facilitates outpatient care by offering durable medical equipment to manufacturers and healthcare providers in the United States.
As a leading provider of ambulatory infusion pumps and supplies to oncologists and outpatient infusion centers, InfuSystem is well-positioned to introduce Dignitana’s DigniCap Scalp Cooling System to its customers. This collaboration will make it easier for healthcare providers to order and receive ongoing support for Dignitana’s innovative scalp cooling solution.
Catarina Löwenadler, Dignitana’s CEO, emphasized the exceptional reputation of InfuSystem for patient-focused product excellence and exceptional service and support. With its widespread access to cancer centers across the United States, this partnership marks a significant stride for Dignitana as it seeks to expand its presence and provide scalp cooling access to a broader range of patients.
Carrie Lachance, President and COO of InfuSystem, expressed her enthusiasm for the partnership, highlighting the value of providing customers with access to the DigniCap Scalp Cooling System—a premium solution for chemotherapy-induced hair loss. She anticipates a long and fruitful relationship between the two companies.
The FDA-cleared DigniCap Scalp Cooling System is a clinically proven solution designed to minimize hair loss resulting from chemotherapy treatment for cancer patients with solid tumors such as breast, ovarian, and prostate cancer.
DigniCap is available in over 260 infusion centers throughout the United States and in more than 30 countries worldwide. Scalp cooling is recommended in the clinical practice guidelines published by organizations such as the National Comprehensive Cancer Network® (NCCN), the European Society for Medical Oncology (ESMO), and Cancer Australia.
Dignitana AB is a global leader in the development of scalp cooling technology for cancer patients. The company is renowned for its innovative product, The DigniCap® Scalp Cooling System, which is a patented medical device designed to help cancer patients reduce hair loss during chemotherapy. This system has been FDA cleared since 2015 and is known for its high efficacy, safety, and patient comfort.
The DigniCap Scalp Cooling System is widely recognized as a groundbreaking advancement in medical care for cancer patients. It was originally conceived in 1999 by a Swedish oncology nurse and has been available in Europe since 2001, providing patients with an effective means to preserve their hair during cancer treatment.
Dignitana AB is listed on the Nasdaq First North Growth Market in Sweden and is headquartered in Lund, Sweden. The company also has a significant presence in the United States, with operations based in Dallas, Texas. Its subsidiaries include Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy.
Redeye AB serves as the company’s Certified Adviser, providing guidance and support in compliance with regulatory requirements and financial markets.
Dignitana AB is committed to improving the quality of life for cancer patients by offering innovative solutions that help minimize the impact of cancer treatments on their appearance and well-being.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU) is a prominent national healthcare service provider that plays a crucial role in facilitating outpatient care for both durable medical equipment manufacturers and healthcare providers. The company operates under a two-platform model to deliver its services effectively.
InfuSystem is headquartered in Rochester Hills, Michigan, and is known for delivering field-based customer support that caters to local needs. Additionally, the company operates Centers of Excellence in multiple locations, including Michigan, Kansas, California, Massachusetts, Texas, and Ontario, Canada.
InfuSystem Holdings is dedicated to enhancing patient care and supporting healthcare providers by delivering vital services and equipment for outpatient care, particularly in cases where durable medical equipment plays a crucial role in patient treatment and well-being.